Literature DB >> 6346104

Multiple organ-reactive monoclonal autoantibodies.

M V Haspel, T Onodera, B S Prabhakar, P R McClintock, K Essani, U R Ray, S Yagihashi, A L Notkins.   

Abstract

Autoantibodies directed against a wide range of normal tissue antigens have been found in the sera of patients with autoimmune diseases. It is generally thought that different and specific autoantibodies react with different tissues but the possibility exists that some autoantibodies may react with common antigens found in different tissues and organs. Recently, we showed that mice infected with reovirus developed a polyendocrine disease with autoantibodies to the pancreas, anterior pituitary, thymus and gastric mucosa. Using hybridoma technology, we obtained a number of monoclonal autoantibodies which reacted with antigens in single organs. We now report the production and pattern of reactivity of seven multiple organ-reactive monoclonal autoantibodies. By using antibody-affinity columns, autoantigens also have been isolated and their molecular weights determined. The results suggest that monoclonal multiple organ-reactive autoantibodies react either with the same molecule present in several organs or with common antigenic determinants on different molecules in multiple organs. In either case, the existence of multiple organ-reactive antibodies may be a partial explanation for multiple organ autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346104     DOI: 10.1038/304073a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  49 in total

1.  A patient with a polyglandular autoimmune syndrome involving the salivary glands, thyroid, intestine, and pancreas.

Authors:  Alan L Buchman; Sambasiva M Rao
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

2.  Sequence-specific binding of normal serum immunoglobulin M to exposed protein C-termini.

Authors:  Alex V Sokoloff; Marissa Puckett; James J Ludtke; Bryan Fetterly
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

3.  The acquisition of narrow binding specificity by polyspecific natural IgM antibodies in a semi-physiological environment.

Authors:  Qili Chu; James J Ludtke; Vladimir M Subbotin; Andrey Blockhin; Alex V Sokoloff
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

4.  Anti-thyroid peroxidase antibody activity in sera of patients with systemic lupus erythematosus.

Authors:  Y Kohno; N Naito; K Saito; A Hoshioka; H Niimi; H Nakajima; T Hosoya
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

5.  Human multiple organ-reactive monoclonal autoantibody recognizes growth hormone and a 35,000-molecular weight protein.

Authors:  J Satoh; K Essani; P R McClintock; A L Notkins
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.

Authors:  S C Cheung; S Takeda; A L Notkins
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 7.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

8.  A ganglioside antigen on the rat pancreatic B cell surface identified by monoclonal antibody R2D6.

Authors:  R Alejandro; F L Shienvold; S A Hajek; M Pierce; R Paul; D H Mintz
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

9.  Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.

Authors:  R L Rubin; R S Balderas; E M Tan; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

10.  Characterization of monoclonal antibodies directed towards the microsomal/microvillar thyroid autoantigen recognized by Hashimoto autoantibodies.

Authors:  J P Banga; R Mirakian; L Hammond; G Pryce; S Bidey; F Bottazzo; A P Weetman; A M McGregor; I M Roitt
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.